Clinical Trial

CVC for Liver Fibrosis in Nonalcoholic Steatohepatitis

Study Description

AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH

The AURORA study will be conducted to confirm the efficacy and safety of cenicriviroc (CVC) for the treatment of liver fibrosis in adult subjects with NASH.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Drug - Cenicriviroc

1 tablet QD

Drug - Placebo

1 tablet QD

Additional Information

Official Study Title

AURORA: A Phase 3 Study to Evaluate the Efficacy and Safety of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects With Nonalcoholic Steatohepatitis

Clinical Trial ID

NCT03028740

ParticipAid ID

yb80gb